Catalyst Wire Dossier Catalyst Wire Dossier

ORP-101

· OrphoMed, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ORP-101, covering 2022-03-04 to 2022-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 2]

See pricing